Article
Impact of myelodysplasia‐related and additional gene mutations in intensively treated patients with NPM1‐mutated AML
1 Jan 2025
Abstract excerpt
ABSTRACT This study aimed to evaluate the impact of the myelodysplasia‐related gene (MRG) as well as additional gene mutations on outcomes in intensively treated patients with NPM1‐mutated (NPM1mut) AML. Targeted DNA sequencing of 263 genes was performed in 568 NPM1mut AML patients (median age: 59 years) entered into the prospective AMLSG 09‐09 treatment trial. Most commonly co‐mutated genes were DNMT3A (49.8%),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
